title: Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
authors.affiliation: Johns Hopkins University Medical Center, Baltimore, Maryland 21205, USA. mpetri@welch.jhu.edu
authors.forename: Michelle A
authors.initials: MA
authors.lastname: Petri
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Mease
authors.forename: Joan T
authors.initials: JT
authors.lastname: Merrill
authors.forename: Robert G
authors.initials: RG
authors.lastname: Lahita
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Iannini
authors.forename: David E
authors.initials: DE
authors.lastname: Yocum
authors.forename: Ellen M
authors.initials: EM
authors.lastname: Ginzler
authors.forename: Robert S
authors.initials: RS
authors.lastname: Katz
authors.forename: Oscar S
authors.initials: OS
authors.lastname: Gluck
authors.forename: Mark C
authors.initials: MC
authors.lastname: Genovese
authors.forename: Ronald
authors.initials: R
authors.lastname: Van Vollenhoven
authors.forename: Kenneth C
authors.initials: KC
authors.lastname: Kalunian
authors.forename: Susan
authors.initials: S
authors.lastname: Manzi
authors.forename: Maria W
authors.initials: MW
authors.lastname: Greenwald
authors.forename: Jill P
authors.initials: JP
authors.lastname: Buyon
authors.forename: Nancy J
authors.initials: NJ
authors.lastname: Olsen
authors.forename: Michael H
authors.initials: MH
authors.lastname: Schiff
authors.forename: Arthur F
authors.initials: AF
authors.lastname: Kavanaugh
authors.forename: Jacques R
authors.initials: JR
authors.lastname: Caldwell
authors.forename: Rosalind
authors.initials: R
authors.lastname: Ramsey-Goldman
authors.forename: E William
authors.initials: EW
authors.lastname: St  Clair
authors.forename: Allan L
authors.initials: AL
authors.lastname: Goldman
authors.forename: Rita M
authors.initials: RM
authors.lastname: Egan
authors.forename: Richard P
authors.initials: RP
authors.lastname: Polisson
authors.forename: Kevin G
authors.initials: KG
authors.lastname: Moder
authors.forename: Naomi F
authors.initials: NF
authors.lastname: Rothfield
authors.forename: Robert T
authors.initials: RT
authors.lastname: Spencer
authors.forename: Kathryn
authors.initials: K
authors.lastname: Hobbs
authors.forename: Barri J
authors.initials: BJ
authors.lastname: Fessler
authors.forename: Leonard H
authors.initials: LH
authors.lastname: Calabrese
authors.forename: Larry W
authors.initials: LW
authors.lastname: Moreland
authors.forename: Stanley B
authors.initials: SB
authors.lastname: Cohen
authors.forename: Betty J
authors.initials: BJ
authors.lastname: Quarles
authors.forename: Vibeke
authors.initials: V
authors.lastname: Strand
authors.forename: Marc
authors.initials: M
authors.lastname: Gurwith
authors.forename: Kenneth E
authors.initials: KE
authors.lastname: Schwartz
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D003687:Dehydroepiandrosterone / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D011446:Prospective Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D003687:Dehydroepiandrosterone